Scarica l'app Stockscreener
91.56
1.52%
1.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Stake Boosted by PNC Financial Services Group Inc. - MarketBeat
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - Yahoo Finance
Boston Sci study shows Watchman Flx better OPTION than DOAC - BioWorld Online
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific stock soars to all-time high of $89.33 - Investing.com
Boston Scientific stock soars to all-time high of $89.33 By Investing.com - Investing.com Canada
Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today - Yahoo Finance
Boston Scientific’s Watchman could be new option for patients post ablation: study - Yahoo Finance
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific reports outcomes from trial of LAAC device - Yahoo Finance
Boston Scientific to Acquire Cortex - Today's Medical Developments
Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial - Quantisnow
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific put volume heavy and directionally bearish - TipRanks
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific Closes Acquisition of Axonics, Inc. - Quantisnow
Boston Scientific Closes Acquisition of Axonics, Inc. – Company Announcement - Financial Times
Boston Scientific closes $3.7B Axonics deal after lengthy review - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Boston Scientific Co. (NYSE:BSX) Shares Bought by Huntington National Bank - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain - Yahoo Finance
Urology Devices Market to Surpass Market Valuation of USD 61.62 Billion by 2031 | SkyQuest Technology - Benzinga
Boston Scientific EVP John Sorenson sells $2.68m in stock - Investing.com
Boston Sci charges ahead with AVANT GUARD PFA trial - BioWorld Online
Boston Scientific To Present At 2024 UBS Global Healthcare Conference; Webcast At 10:15 AM ET - Nasdaq
Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance
BSXBoston Scientific Corp. Latest Stock News & Market Updates - StockTitan
Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now - Insider Monkey
Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds - Insider Monkey
Van ECK Associates Corp Has $5.06 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
8 Hot Growth Stocks To Buy According to Hedge Funds - Insider Monkey
Boston Scientific stock soars to all-time high of $88.81 - Investing.com
We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Petri Dish: Boston Scientific resumes atrial fibrillation trial; Seaport hires CFO - The Business Journals
Boston Scientific CEO sells shares worth $13.8 million By Investing.com - Investing.com Canada
Boston Scientific CEO sells shares worth $13.8 million - Investing.com
Boston Scientific Corp. stock rises Thursday, still underperforms market - MarketWatch
Boston Scientific (BSX) Resumes AVANT GUARD Clinical Trial for A - GuruFocus.com
Boston Scientific resumes AVANT GUARD trial - Investing.com
Kidney Stone Management Market Forecast Report, 2024-2032Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share - Yahoo Finance
Boston Scientific Resumes AVANT GUARD Clinical Trial - TipRanks
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch
Boston Scientific to Speak at Conference - Baystreet.ca
Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference – Company Announcement - Financial Times
Boston Scientific to bolster cardiac ablation portfolio with Cortex acquisition - Medical Device Network
Heritage Investors Management Corp Sells 7,684 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end - MSN
Boston Sci to acquire Cortex, expand AF portfolio - BioWorld Online
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock - Investing.com
Boston Scientific EVP Wendy Carruthers sells $588,876 in stock By Investing.com - Investing.com UK
Are Wall Street Analysts Bullish on Boston Scientific Stock? - Nasdaq
Are Wall Street Analysts Bullish On Boston Scientific Stock? - Barchart
TD Cowen maintains Buy rating on Boston Scientific with $100 target - Investing.com
Boston Scientific continues M&A run with Cortex buy - Yahoo Finance
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - Financial Times
1.10%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):